日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis

微生物群落组织可区分不同的肺部急性加重类型,并预测囊性纤维化的治疗结果

Widder, Stefanie; Carmody, Lisa A; Opron, Kristopher; Kalikin, Linda M; Caverly, Lindsay J; LiPuma, John J

Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes

量化囊性纤维化患者基线健康状态下家庭肺功能测定结果的变化及其与临床结局的关联

Thornton, Christina S; Magaret, Amalia S; Carmody, Lisa A; Kalikin, Linda M; Simon, Richard H; LiPuma, John J; Caverly, Lindsay J

Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations

囊性纤维化肺部急性加重STOP2研究中呼吸道病毒感染的患病率和临床影响

Thornton, Christina S; Caverly, Lindsay J; Kalikin, Linda M; Carmody, Lisa A; McClellan, Scott; LeBar, William; Sanders, Don B; West, Natalie E; Goss, Christopher H; Flume, Patrick A; Heltshe, Sonya L; VanDevanter, Donald R; LiPuma, John J

Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis

微生物群落组织可区分不同的肺部急性加重类型,并预测囊性纤维化的治疗结果

Widder, Stefanie; Carmody, Lisa; Opron, Kristopher; Kalikin, Linda; Caverly, Lindsay; LiPuma, John

Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways

囊性纤维化气道中细菌群落类型、功能性微生物过程与肺部疾病的关联

Widder, Stefanie; Zhao, Jiangchao; Carmody, Lisa A; Zhang, Qingyang; Kalikin, Linda M; Schloss, Patrick D; LiPuma, John J

Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis

囊性纤维化肺部急性加重开始使用抗生素治疗后不久,气道细菌群落就会发生变化

Carmody, Lisa A; Kalikin, Linda M; VanDevanter, Donald R; Li, Gen; Opron, Kristopher; Simon, Richard H; Caverly, Lindsay J; LiPuma, John J

Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis

液相色谱质谱法检测囊性纤维化患者痰液中的抗生素

Gallagher, Tara; Riedel, Stefan; Kapcia, Joseph; Caverly, Lindsay J; Carmody, Lisa; Kalikin, Linda M; Lu, Junnan; Phan, Joann; Gargus, Matthew; Kagawa, Miki; Leemans, Simon W; Rothman, Jason A; Grun, Felix; LiPuma, John J; Whiteson, Katrine L

Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability

囊性纤维化气道微生物群在临床稳定期的测量

Caverly, Lindsay J; Lu, Junnan; Carmody, Lisa A; Kalikin, Linda M; Shedden, Kerby; Opron, Kristopher; Azar, Michelle; Cahalan, Shannon; Foster, Bridget; VanDevanter, Donald R; Simon, Richard H; LiPuma, John J

In Vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens

β-内酰胺类-β-内酰胺酶抑制剂抗菌剂对囊性纤维化呼吸道病原体的体外活性

Caverly, Lindsay J; Spilker, Theodore; Kalikin, Linda M; Stillwell, Terri; Young, Carol; Huang, David B; LiPuma, John J

Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis

囊性纤维化患者气道细菌群落的波动与临床状态和疾病阶段相关

Carmody, Lisa A; Caverly, Lindsay J; Foster, Bridget K; Rogers, Mary A M; Kalikin, Linda M; Simon, Richard H; VanDevanter, Donald R; LiPuma, John J